Literature DB >> 16765607

RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling.

Caroline Nunn1, Helen Mao, Peter Chidiac, Paul R Albert.   

Abstract

Regulators of G-protein signaling (RGS proteins) comprise over 20 different proteins that have been classified into subfamilies on the basis of structural homology. The RZ/A family includes RGSZ2/RGS17 (the most recently discovered member of this family), GAIP/RGS19, RGSZ1/RGS20, and the RGSZ1 variant Ret-RGS. The RGS proteins are GTPase activating proteins (GAPs) that turn off G-proteins and thus negatively regulate the signaling of G-protein coupled receptors (GPCRs). In addition, some RZ/A family RGS proteins are able to modify signaling through interactions with adapter proteins (such as GIPC and GIPN). The RZ/A proteins have a simple structure that includes a conserved amino-terminal cysteine string motif, RGS box and short carboxyl-terminal, which confer GAP activity (RGS box) and the ability to undergo covalent modification and interact with other proteins (amino-terminal). This review focuses on RGS17 and its RZ/A sibling proteins and discusses the similarities and differences among these proteins in terms of their palmitoylation, phosphorylation, intracellular localization and interactions with GPCRs and adapter proteins. The specificity of these RGS protein for different Galpha proteins and receptors, and the consequences for signaling are discussed. The tissue and brain distribution, and the evolving understanding of the roles of this family of RGS proteins in receptor signaling and brain function are highlighted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765607     DOI: 10.1016/j.semcdb.2006.04.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  19 in total

Review 1.  Regulation of neurite outgrowth by G(i/o) signaling pathways.

Authors:  Kenneth D Bromberg; Ravi Iyengar; John Cijiang He
Journal:  Front Biosci       Date:  2008-05-01

Review 2.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  High-resolution structure of RGS17 suggests a role for Ca2+ in promoting the GTPase-activating protein activity by RZ subfamily members.

Authors:  Monita Sieng; Michael P Hayes; Joseph B O'Brien; C Andrew Fowler; Jon C Houtman; David L Roman; Angeline M Lyon
Journal:  J Biol Chem       Date:  2019-04-02       Impact factor: 5.157

Review 4.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 5.  Regulators of G-protein signaling in the heart and their potential as therapeutic targets.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

6.  Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.

Authors:  Shelley B Hooks; Phillip Callihan; Molly K Altman; Jillian H Hurst; Mourad W Ali; Mandi M Murph
Journal:  Mol Cancer       Date:  2010-11-02       Impact factor: 27.401

7.  Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene.

Authors:  Ming You; Daolong Wang; Pengyuan Liu; Haris Vikis; Michael James; Yan Lu; Yian Wang; Min Wang; Qiong Chen; Dongmei Jia; Yan Liu; Weidong Wen; Ping Yang; Zhifu Sun; Susan M Pinney; Wei Zheng; Xiao-Ou Shu; Jirong Long; Yu-Tang Gao; Yong-Bing Xiang; Wong-Ho Chow; Nat Rothman; Gloria M Petersen; Mariza de Andrade; Yanhong Wu; Julie M Cunningham; Jonathan S Wiest; Pamela R Fain; Ann G Schwartz; Luc Girard; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Teresa Coons; Juwon Lee; Elena Kupert; Daniela Seminara; John Minna; Joan E Bailey-Wilson; Christopher I Amos; Marshall W Anderson
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  RGS17: an emerging therapeutic target for lung and prostate cancers.

Authors:  Christopher R Bodle; Duncan I Mackie; David L Roman
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

9.  RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.

Authors:  Michael A James; Yan Lu; Yan Liu; Haris G Vikis; Ming You
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

Review 10.  The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.

Authors:  John H Kehrl
Journal:  Biochem Pharmacol       Date:  2016-04-09       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.